Other frequent genomic alterations in melanoma include deletion or inactivating mutations of PTEN and CDKN2A, amplifications or activating mutations of NRAS, AKT, CCND1, MITF, KIT, and TERT, among others [2]. This evidence concerns the gene PTEN and melanoma.